Cargando…

Long-Term and Interactive Effects of Pay-For-Performance Interventions among Diabetic Nephropathy Patients at the Early Chronic Kidney Disease Stage

Chronic kidney disease (CKD) is a major health problem worldwide because of the aging population and lifestyle changes. One of the important etiologies of CKD is diabetes mellitus (DM). The long-term effects of pay-for-performance (P4P) on disease progression have not been thoroughly examined. This...

Descripción completa

Detalles Bibliográficos
Autores principales: Liao, Pei-Ju, Lin, Tzu-Yu, Wang, Tzu-Ching, Ting, Ming-Kuo, Wu, I-Wen, Huang, Hsin-Tsung, Wang, Fu-Chung, Chang, Huan-Cheng, Hsu, Kuang-Hung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4998808/
https://www.ncbi.nlm.nih.gov/pubmed/27057892
http://dx.doi.org/10.1097/MD.0000000000003282
_version_ 1782450011676606464
author Liao, Pei-Ju
Lin, Tzu-Yu
Wang, Tzu-Ching
Ting, Ming-Kuo
Wu, I-Wen
Huang, Hsin-Tsung
Wang, Fu-Chung
Chang, Huan-Cheng
Hsu, Kuang-Hung
author_facet Liao, Pei-Ju
Lin, Tzu-Yu
Wang, Tzu-Ching
Ting, Ming-Kuo
Wu, I-Wen
Huang, Hsin-Tsung
Wang, Fu-Chung
Chang, Huan-Cheng
Hsu, Kuang-Hung
author_sort Liao, Pei-Ju
collection PubMed
description Chronic kidney disease (CKD) is a major health problem worldwide because of the aging population and lifestyle changes. One of the important etiologies of CKD is diabetes mellitus (DM). The long-term effects of pay-for-performance (P4P) on disease progression have not been thoroughly examined. This study is a retrospective population-based patient cohort design to examine the continuous effects of diabetes and CKD P4P interventions. This study used the health insurance claims database to conduct a longitudinal analysis. A total of 32,084 early CKD patients with diabetes were extracted from the outpatient claims database from January 2011 to December 2012, and the follow-up period was extended to August 2014. A 4-group matching design, including both diabetes and early CKD P4P interventions, with only diabetes P4P intervention, with only early CKD P4P intervention, and without any P4P interventions, was performed according to their descending intensity. The primary outcome of this study was all-cause mortality and the causes of death. The statistical methods included a Chi-squared test, ANOVA, and multi-variable Cox regression models. A dose–response relationship between the intervention groups and all-cause mortality was observed as follows: comparing to both diabetes and early CKD P4P interventions (reference), hazard ratio (HR) was 1.22 (95% confidence interval [CI], 1.00–1.50) for patients with only a diabetes P4P intervention; HR was 2.00 (95% CI, 1.66–2.42) for patients with only an early CKD P4P intervention; and HR was 2.42 (95% CI, 2.02–2.91) for patients without any P4P interventions. The leading cause of death of the total diabetic nephropathy patient cohort was infectious diseases (34.32%) followed by cardiovascular diseases (17.12%), acute renal failure (1.50%), and malignant neoplasm of liver (1.40%). Because the earlier interventions have lasting long-term effects on the patient's prognosis regardless of disease course, an integrated early intervention plan is suggested in future care plan designs. The mechanisms regarding the effects of P4P intervention, such as health education on diet control, continuity of care, and practice guidelines and adherence, are the primary components of disease management programs.
format Online
Article
Text
id pubmed-4998808
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-49988082016-08-29 Long-Term and Interactive Effects of Pay-For-Performance Interventions among Diabetic Nephropathy Patients at the Early Chronic Kidney Disease Stage Liao, Pei-Ju Lin, Tzu-Yu Wang, Tzu-Ching Ting, Ming-Kuo Wu, I-Wen Huang, Hsin-Tsung Wang, Fu-Chung Chang, Huan-Cheng Hsu, Kuang-Hung Medicine (Baltimore) 4400 Chronic kidney disease (CKD) is a major health problem worldwide because of the aging population and lifestyle changes. One of the important etiologies of CKD is diabetes mellitus (DM). The long-term effects of pay-for-performance (P4P) on disease progression have not been thoroughly examined. This study is a retrospective population-based patient cohort design to examine the continuous effects of diabetes and CKD P4P interventions. This study used the health insurance claims database to conduct a longitudinal analysis. A total of 32,084 early CKD patients with diabetes were extracted from the outpatient claims database from January 2011 to December 2012, and the follow-up period was extended to August 2014. A 4-group matching design, including both diabetes and early CKD P4P interventions, with only diabetes P4P intervention, with only early CKD P4P intervention, and without any P4P interventions, was performed according to their descending intensity. The primary outcome of this study was all-cause mortality and the causes of death. The statistical methods included a Chi-squared test, ANOVA, and multi-variable Cox regression models. A dose–response relationship between the intervention groups and all-cause mortality was observed as follows: comparing to both diabetes and early CKD P4P interventions (reference), hazard ratio (HR) was 1.22 (95% confidence interval [CI], 1.00–1.50) for patients with only a diabetes P4P intervention; HR was 2.00 (95% CI, 1.66–2.42) for patients with only an early CKD P4P intervention; and HR was 2.42 (95% CI, 2.02–2.91) for patients without any P4P interventions. The leading cause of death of the total diabetic nephropathy patient cohort was infectious diseases (34.32%) followed by cardiovascular diseases (17.12%), acute renal failure (1.50%), and malignant neoplasm of liver (1.40%). Because the earlier interventions have lasting long-term effects on the patient's prognosis regardless of disease course, an integrated early intervention plan is suggested in future care plan designs. The mechanisms regarding the effects of P4P intervention, such as health education on diet control, continuity of care, and practice guidelines and adherence, are the primary components of disease management programs. Wolters Kluwer Health 2016-04-08 /pmc/articles/PMC4998808/ /pubmed/27057892 http://dx.doi.org/10.1097/MD.0000000000003282 Text en Copyright © 2016 Wolters Kluwer Health, Inc. All rights reserved. http://creativecommons.org/licenses/by-nc-nd/4.0 This is an open access article distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0, where it is permissible to download, share and reproduce the work in any medium, provided it is properly cited. The work cannot be changed in any way or used commercially. http://creativecommons.org/licenses/by-nc-nd/4.0
spellingShingle 4400
Liao, Pei-Ju
Lin, Tzu-Yu
Wang, Tzu-Ching
Ting, Ming-Kuo
Wu, I-Wen
Huang, Hsin-Tsung
Wang, Fu-Chung
Chang, Huan-Cheng
Hsu, Kuang-Hung
Long-Term and Interactive Effects of Pay-For-Performance Interventions among Diabetic Nephropathy Patients at the Early Chronic Kidney Disease Stage
title Long-Term and Interactive Effects of Pay-For-Performance Interventions among Diabetic Nephropathy Patients at the Early Chronic Kidney Disease Stage
title_full Long-Term and Interactive Effects of Pay-For-Performance Interventions among Diabetic Nephropathy Patients at the Early Chronic Kidney Disease Stage
title_fullStr Long-Term and Interactive Effects of Pay-For-Performance Interventions among Diabetic Nephropathy Patients at the Early Chronic Kidney Disease Stage
title_full_unstemmed Long-Term and Interactive Effects of Pay-For-Performance Interventions among Diabetic Nephropathy Patients at the Early Chronic Kidney Disease Stage
title_short Long-Term and Interactive Effects of Pay-For-Performance Interventions among Diabetic Nephropathy Patients at the Early Chronic Kidney Disease Stage
title_sort long-term and interactive effects of pay-for-performance interventions among diabetic nephropathy patients at the early chronic kidney disease stage
topic 4400
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4998808/
https://www.ncbi.nlm.nih.gov/pubmed/27057892
http://dx.doi.org/10.1097/MD.0000000000003282
work_keys_str_mv AT liaopeiju longtermandinteractiveeffectsofpayforperformanceinterventionsamongdiabeticnephropathypatientsattheearlychronickidneydiseasestage
AT lintzuyu longtermandinteractiveeffectsofpayforperformanceinterventionsamongdiabeticnephropathypatientsattheearlychronickidneydiseasestage
AT wangtzuching longtermandinteractiveeffectsofpayforperformanceinterventionsamongdiabeticnephropathypatientsattheearlychronickidneydiseasestage
AT tingmingkuo longtermandinteractiveeffectsofpayforperformanceinterventionsamongdiabeticnephropathypatientsattheearlychronickidneydiseasestage
AT wuiwen longtermandinteractiveeffectsofpayforperformanceinterventionsamongdiabeticnephropathypatientsattheearlychronickidneydiseasestage
AT huanghsintsung longtermandinteractiveeffectsofpayforperformanceinterventionsamongdiabeticnephropathypatientsattheearlychronickidneydiseasestage
AT wangfuchung longtermandinteractiveeffectsofpayforperformanceinterventionsamongdiabeticnephropathypatientsattheearlychronickidneydiseasestage
AT changhuancheng longtermandinteractiveeffectsofpayforperformanceinterventionsamongdiabeticnephropathypatientsattheearlychronickidneydiseasestage
AT hsukuanghung longtermandinteractiveeffectsofpayforperformanceinterventionsamongdiabeticnephropathypatientsattheearlychronickidneydiseasestage